Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Rom J Morphol Embryol ; 58(4): 1471-1476, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29556643

RESUMO

Mucosal malignant melanoma is an extremely rare tumor of the nose, with an aggressive character, low prognosis and frequent recurrences. The authors present a case of a 60-year-old male patient, diagnosed five years ago with adenoid cystic carcinoma, for which he had surgery and radiotherapy, who was admitted in our Clinic with unilateral epistaxis and obstruction of the nasal cavity. Clinical exam revealed an obstructive polypoidal bleeding mass of the left nasal cavity. Biopsy was performed and the histopathological exam showed malignant mucosal melanoma. Wide local endoscopic surgery was practiced for two times in the last two years, and for now, there is no recurrence. Malignant melanomas are tumors with high mortality rate, which necessitate an early diagnosis and immediate treatment.


Assuntos
Melanoma/diagnóstico , Cavidade Nasal/patologia , Neoplasias Nasais/diagnóstico , Humanos , Masculino , Melanoma/patologia , Melanoma/terapia , Pessoa de Meia-Idade , Neoplasias Nasais/patologia , Neoplasias Nasais/terapia
2.
Rom J Morphol Embryol ; 56(2 Suppl): 817-22, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26429178

RESUMO

Ocular melanoma is a rare malignancy found in clinical practice. In this paper, we present a case of highly aggressive ocular melanoma, which was surgically removed at the Department of Ophthalmology and diagnosed at the Department of Pathology, Emergency University Hospital, Bucharest, Romania, using conventional histopathological techniques. Uveal melanoma, a subset of ocular melanoma, has a distinct behavior in comparison to cutaneous melanoma and has a widely divergent prognosis. Approximately half of patients with ocular melanoma will develop metastatic disease, predominantly with hepatic, pulmonary or cerebral location, over a 10 to 15 years period. No systemic therapy was associated with an evident clinical outcome for patients with advanced disease and overall survival rate remains poor.


Assuntos
Melanoma/diagnóstico , Melanoma/cirurgia , Neoplasias Uveais/diagnóstico , Neoplasias Uveais/cirurgia , Proliferação de Células , Feminino , Humanos , Imuno-Histoquímica , Melanoma/patologia , Pessoa de Meia-Idade , Metástase Neoplásica , Oftalmologia , Neoplasias Orbitárias/diagnóstico , Neoplasias Orbitárias/patologia , Neoplasias Orbitárias/cirurgia , Prognóstico , Neoplasias Cutâneas , Fatores de Tempo , Neoplasias Uveais/patologia , Melanoma Maligno Cutâneo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA